Status:
UNKNOWN
Desogestrel Versus GnRH Antagonist in IVF/ICSI
Lead Sponsor:
Casa di Cura Privata Villa Mafalda
Conditions:
IVF
Infertility
Eligibility:
FEMALE
18-42 years
Phase:
PHASE4
Brief Summary
Progestin primed ovarian stimulation (PPOS) has been shown to be effective in avoiding premature spontaneous ovulation, without affecting the number of retrieved oocytes or the quality of the embryos ...
Detailed Description
Study design A prospective controlled randomized clinical trial (RCT) will be conducted to assess the non inferiority of Desogestrel (75 mcg) versus a flexible GnRH antagonist protocol with ganirelix ...
Eligibility Criteria
Inclusion
- regular menstrual cycles over the previous 3-month period (25 - 35 days in duration)
- basal serum FSH concentration of no more than 10 IU/L
Exclusion
- documented ovarian failure, including basal FSH above 10 IU/L or no antral follicles by ultrasound examination
- diagnosis of polycystic ovarian syndrome
- any controindication to ovarian stimulation treatment.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2022
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT04728659
Start Date
October 1 2020
End Date
February 28 2022
Last Update
January 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Villa Mafalda
Roma, Italy